InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$86.04

2026-10-16

Market Cap

$32.5B

Volume

3.5M

52-Wk High

$92.59

52-Wk Low

$54.11

Trailing PE

33.2

P/S

6.53

Gross Margin

62.5%

Net Margin

20.1%

ROE

36%

ROIC

22%

Piotroski

8/9

Altman Z

7.5

1-Yr Return

+29.7%

5-Yr Return

+104.5%

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

SectorHealthcareIndustryMedical - DevicesExchangeNASDAQMarket Cap$32.5BEmployees11,000 (SEC-filed)CEOJacob Steven LeachIPO2005-04-14CountryUS

6340 Sequence Drive, San Diego, CA 92121 · Tel 858 200 0200 · dexcom.com

INSIDERSTREET SCORE81 / 100Street mean $97.57 (14 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$12M sold / 6 mo, zero open-market buys

1 Year vs S&P 500 · DXCM +29.7% · S&P 500 +15.9% · spread +13.8pp

7 Years vs S&P 500 · DXCM +104.5% · S&P 500 +189.9% · spread -85.4pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

INSIDERSTREET
SCORE81of 100

Score Breakdown

Profitability	83/100
Growth	72/100
Momentum	94/100
Quality	91/100
Earnings Quality	53/100
Balance Sheet	86/100
Value	32/100
Risk (safety)	100/100
Overall	80.9/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
EW	65
ZBH	60
BSX	67
PEN	68
SNN	76
ALGN	64
DXCM	81

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 81 in 26 Q1, latest 81 — -0 since. Fell in 1 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

BUSINESS QUALITY81 / 100IS Score 80.9 / 100 · -0.1 from peak of 81

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTURENEUTRALTechnical Score 50 / 100 · Power -1 · 14 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 81 and price structure at 50 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 80.9	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 70 → 79 → 81 → 81	the direction matters more than the level
Technical vote share back above 50%	now 45%	price structure no longer broken
Institutional holder count rises two quarters running	peak 1,042 → now 977	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score3 of 4top 4% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)1 buys2026-05-01

Insider Buys (180d)0none disclosed

ETF Funds (30d)1153 up / 1111 downnet +42 funds

Institutions Added (13F)14managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Institutions holding — 12 quarters

Peak 1,042 · latest 977 (-65 from peak).

Quarter	Holders	13F shares	Value	Reported own%	Guard
2026 Q2	977	389.4M	$25.8B	101.5%	ex-outlier 91.5%
2026 Q1	963	366.3M	$22.6B	95.5%
2025 Q4	926	369.9M	$24.0B	96.4%
2025 Q3	914	438.2M	$24.3B	114.2%	ex-outlier 96.2%
2025 Q2	945	370.3M	$31.6B	96.5%
2025 Q1	936	364.7M	$24.6B	95.0%
2024 Q4	954	358.8M	$27.5B	93.5%
2024 Q3	892	361.5M	$23.7B	94.2%
2024 Q2	1,003	374.4M	$41.8B	97.6%
2024 Q1	1,042	368.8M	$50.3B	96.1%
2023 Q4	980	378.3M	$46.0B	98.6%
2023 Q3	903	368.8M	$34.0B	96.1%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

Why 2026-06 reads 101.49%. Institutions cannot hold more of a company than exists. The reported 389.4M shares exceed the 383.7M outstanding, and a single filer accounts for the excess: BlackRock, Inc. reports 38,244,137 shares against 38,964,371 the prior quarter, a 1x jump, which alone would be 10.0% of the company. Excluding that filing, ownership is 91.5%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.

Why 2025-09 reads 114.20%. Institutions cannot hold more of a company than exists. The reported 438.2M shares exceed the 383.7M outstanding, and a single filer accounts for the excess: TUDOR INVESTMENT CORP ET AL reports 69,150,000 shares, which alone would be 18.0% of the company. Excluding that filing, ownership is 96.2%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Stern Sadie	EVP Chief People & Culture Off	2026-09-28	SELL	2,565	$0.22M	123,478
Augustinos Nicholas	director	2026-09-15	SELL	6,539	$0.55M	29,293
Brown Michael Jon	EVP Chief Legal Compliance Off	2026-09-15	SELL	1,700	$0.14M	99,885
Augustinos Nicholas	director	2026-09-14	SELL	1,550	$0.13M	35,832
Sylvain Jereme M	EVP, Chief Financal Officer	2026-09-10	SELL	3,638	$0.30M	146,828
Boehnlein Glenn S	director	2026-09-10	A-Award	5,841	—	5,841
Stern Sadie	EVP Chief People & Culture Off	2026-08-27	SELL	2,565	$0.23M	126,043
Leach Jacob Steven	director, President, CEO, and Director	2026-08-22	TAX W/H	1,451	$0.13M	418,908

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	26	155,631	$12.1M	Counted
F — Tax withholding	14	130,699	$9.1M	None — compensation
G — Gifts	4	20,888	—	None
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$12.1M26 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-10-15	Michael Brown	1,700	$0.1M
2026-09-28	Sadie Stern	2,565	$0.2M
2026-09-15	Augustinos Nicholas	6,539	$0.5M
2026-09-15	Michael Brown	1,700	$0.1M
Trailing 12 mo	29 filings	169,466	$13M

Filed	Form	Reporting person	% of class	Shares
2026-04-29	SCHEDULE 13G	Vanguard Portfolio Management	5.02%	19.3M sh
2026-04-29	SCHEDULE 13G	Vanguard Capital Management	7.49%	28.8M sh
2025-10-30	SCHEDULE 13G/A	The Vanguard Group	12.61%	49.5M sh
2025-04-24	SCHEDULE 13G/A	BlackRock, Inc.	8.30%	32.5M sh

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	BUY	$1,001 - $15,000	2026-05-01	2026-06-11
Ro Khanna	House	BUY	$1,001 - $15,000	2026-04-13	2026-05-13
Ro Khanna	House	BUY	$1,001 - $15,000	2026-01-29	2026-02-10
John Boozman	Senate	BUY	$1,001 - $15,000	2026-01-26	2026-02-15
John Boozman	Senate	BUY	$1,001 - $15,000	2026-01-26	2026-02-14
John Boozman	Senate	BUY	$1,001 - $15,000	2026-01-26	2026-02-14

House 12-Mo6 trades5 purchases

Senate 12-Mo3 trades3 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

13F Filers (last complete Q)963

13F Shares366M95.5% of shares out

New / Closed148 / 91positions, QoQ

Increased / Reduced378 / 325positions, QoQ

Put/Call (13F)0.84option positions

Free Float99.6%376M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Chicago Capital, Llc	864,397	$75M
Fisher Funds Management Ltd	304,933	$26M
Assenagon Asset Management S.A.	271,350	$23M
Beacon Investment Advisory Service	236,356	$20M
Gradient Investments Llc	236,283	$20M
Fjarde Ap-Fonden /Fourth Swedish N	155,667	$13M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.0%	$1.0B
VTSAX	0.0%	$1.0B
VSMPX	0.0%	$1.0B
VTI	0.0%	$1.0B
VFFSX	0.0%	$855M
VFIAX	0.0%	$855M

13F Filers Holding DXCM — quarterly

Institutional Put/Call — quarterly

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session71.3%2026-10-15

20-Day Avg53.5%50-day 54.1%

TrendFalling20d vs 50d

By Market CenterQ: 71% · N: 91% · B: 77%latest session

Weekly Notional ($B)

Where DXCM Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Ubsa Ubs Ats	4.2M	59 sh
Incr Intelligent Cross Llc	4.1M	50 sh
Sgmt Sigma X2	2.7M	53 sh
Ebxl Level Ats	2.4M	35 sh
Mstx Ms Trajectory Cross (Ats-1)	2.1M	56 sh
Pure Purestream	2.0M	42 sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Where a dollar of DexCom, Inc. revenue goes. All values FY2025 filings, live. Product segmentation not yet parsed for this symbol — revenue shown unsegmented.

DXCM (live moat model)Peer median: EW · ZBH · BSX · PEN · SNN

Component scores from the live moat model. Peer median illustrative.

Moat score 61/100 — Narrow; primary source Cost Advantage.

3.8 · Employees (SEC filings)

Officer	Title
Kevin Ronald Sayer	Executive Chairman of the Board
Jacob Steven Leach	President, CEO & Director
Jereme Sylvain	Executive VP, CFO, COO & Chief Accounting Officer
Michael Brown	Executive VP, Chief Legal & Compliance Officer

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

Quarterly EPS — Actual vs. Consensus

Beats (>2%)5 of 6recent quarters

Avg Surprise+8.6%

Next Report2026-10-29

Income Quality1.75OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Profit Margins (%)

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+27.1%	+18.8%	+24.5%	+11.3%	+15.6%
Gross profit	+31.3%	+12.1%	+21.5%	+6.5%	+14.9%
Operating income	-11.3%	+47.2%	+52.8%	+0.4%	+52.0%
Net income	-56.1%	+57.3%	+58.7%	+6.4%	+45.1%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	2.4	2.9	3.6	4.0	4.7
Cost of revenue	0.8	1.0	1.3	1.6	1.9
Gross profit	1.7	1.9	2.3	2.4	2.8
R&D expense	0.6	0.5	0.5	0.6	0.6
SG&A expense	0.8	1.0	1.2	1.3	1.3
Operating income	0.3	0.4	0.6	0.6	0.9
EBITDA	0.4	0.6	0.9	0.9	1.2
D&A	0.1	0.2	0.2	0.2	0.3
Pretax income	0.3	0.4	0.7	0.7	1.1
Income tax	0.0	0.0	0.2	0.1	0.3
Net income	0.2	0.3	0.5	0.6	0.8
Diluted EPS ($)	0.51	0.80	1.30	1.42	2.09
Diluted shares (M)	429	428	426	413	406

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Operating CF$1B

CapEx$0B

Free cash flow$1B

SBC$0B

Buybacks$0B

Net cash change$0B

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	0.6	0.6	0.6	0.9
ST investments	1.8	2.2	2.0	1.1
Receivables (net)	0.8	1.0	1.0	1.3
Total current assets	3.7	4.4	4.3	4.0
PP&E (net)	1.1	1.2	1.4	1.6
Goodwill + intangibles	0.2	0.2	0.1	0.1
Total assets	5.4	6.3	6.5	6.3
Accounts payable	0.2	0.3	0.3	0.3
Short-term debt	0.8	0.0	1.2	0.0
Deferred revenue	0.0	0.0	0.0	0.0
Total current liabilities	1.8	1.6	2.9	2.1
Long-term debt	1.2	2.4	1.2	1.2
Total liabilities	3.3	4.2	4.4	3.6
Shareholders' equity	2.1	2.1	2.1	2.7

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	0.3	0.5	0.6	0.8
D&A	0.2	0.2	0.2	0.3
Stock-based compensation	0.1	0.2	0.2	0.2
Working capital change	0.0	0.0	0.1	0.1
Operating cash flow	0.7	0.7	1.0	1.4
Capital expenditures	(0.4)	(0.2)	(0.4)	(0.4)
Investing cash flow	(0.5)	(0.5)	(0.2)	0.5
Buybacks	(0.6)	(0.7)	(0.8)	(0.5)
Dividends paid	0.0	0.0	0.0	0.0
Debt issuance / (repay)	0.0	0.4	0.0	(1.2)
Financing cash flow	(0.6)	(0.3)	(0.7)	(1.7)
Free cash flow	0.3	0.5	0.6	1.1

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	8.0%	16.3%	25.8%	27.6%	34.5%	36%
ROA	3.4%	6.6%	9.3%	9.0%	13.0%	15.5%
ROIC	15.9%	18.8%	23.5%	23.1%	32.8%	21.6%
Gross margin	68.6%	64.7%	63.2%	60.5%	60.1%	62.5%
Operating margin	10.9%	13.4%	16.5%	14.9%	19.6%	22.9%
Net margin	8.9%	11.7%	14.9%	14.3%	17.9%	20.1%
EBITDA margin	15.4%	19.4%	25.3%	23.4%	25.0%	31.4%
FCF margin	2.2%	10.5%	14.1%	15.6%	23.1%	—
VALUATION
P/E	336.68	141.35	95.31	54.89	31.66	33.2
P/B	25.51	22.62	24.95	15.04	9.64	12.6
P/S	21.27	16.57	14.25	7.84	5.68	6.53
P/FCF	977.21	158.28	100.82	50.15	24.58	23.1
EV/EBITDA	135.81	84.65	56.16	33.45	19.04	21.0
EV/Revenue	21.04	16.47	14.21	7.84	5.55	6.6
Earnings yield	0.3%	0.7%	1.0%	1.8%	3.2%	3.03%
FCF yield	0.1%	0.6%	1.0%	2.0%	4.1%	4.33%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	5.11	1.99	2.84	1.47	1.88	1.73
Quick ratio	4.62	1.83	2.48	1.28	1.59	1.43
Debt / equity	1.06	1.01	1.25	1.23	0.51	0.53
Debt / assets	43.7%	39.8%	41.4%	39.9%	21.9%	21.7%
Net debt / EBITDA	-1.51	-0.55	-0.14	0.01	-0.45	0.19
Interest coverage	14.75	21.14	36.00	38.32	60.48	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	0.53	0.56	0.62	0.63	0.73	0.77
Receivables turnover	5.19	4.74	4.29	4.07	4.20	3.9
DSO (days)	70	77	85	90	87	94
DPO (days)	84	76	70	71	68	83
Cash conversion cycle	127	119	133	145	134	153
GROWTH (YoY)
Revenue growth	27.1%	18.8%	24.5%	11.3%	15.6%	—
Net income growth	-68.7%	120.6%	58.7%	6.4%	45.1%	—
EPS growth	-68.5%	100.9%	62.5%	8.8%	48.0%	—
FCF growth	-80.7%	471.7%	68.0%	23.2%	70.8%	—
PER SHARE ($)
EPS (diluted, TTM)	0.40	0.80	1.30	1.42	2.10	2.61
Book value / share	5.26	5.01	4.97	5.17	6.88	6.83
Revenue / share	6.31	6.83	8.71	9.92	11.69	12.95
FCF / share	0.14	0.72	1.23	1.55	2.70	3.66
Cash / share	7.04	5.77	6.55	6.34	5.01	5.07
SHAREHOLDER RETURN & SCORES
Buyback yield	0.0%	1.2%	1.3%	2.4%	1.9%	4.18%
Altman Z-Score	12.25	10.20	9.12	5.92	6.63	7.5
Piotroski F-Score	5	6	7	7	9	8/9
Beneish M-Score	-2.43	-2.16	-2.28	-2.62	-2.78	-3.13

Model	Score	Zone	Note
Piotroski F-Score	8 / 9	Strong
Altman Z-Score	7.5	Safe (>2.99)	Safe
Income quality	1.75	Cash-backed	OCF ÷ net income
Beneish M-Score	-3.13	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.78
Interest burden	0.99
Operating margin	26.1%
Asset turnover	0.72×
Financial leverage	2.65×
= ROE	38%

Growth Quality (live)	Value
Revenue stability	0.99
Earnings stability	0.54
Earnings persistence	0.50
Revenue CAGR 3y	15.8%
EPS CAGR 3y	45.5%
FCF CAGR 3y	44.5%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield4.18%

Dividend Yield0.00%none paid

Total Shareholder Return4.08%cash yield

SBC / Revenue3.3%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
EW	$49.9B	49.8	9%	13.9%	+14.6%	6/9	+19.2%
ZBH	$18.1B	23.0	6%	9.1%	+8.6%	6/9	-5.0%
BSX	$64.3B	17.9	15%	16.7%	+13.5%	8/9	-54.6%
PEN	$12.6B	78.4	11%	8.9%	+17.6%	6/9	+26.4%
SNN	$12.2B	19.0	22%	9.8%	+11.5%	8/9	—
ALGN	$10.5B	25.6	10%	10.3%	+4.4%	7/9	—
GMED	$10.3B	19.3	12%	19.2%	+19.7%	8/9	—
PODD	$9.8B	26.3	26%	11.8%	+29.4%	9/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

52 Analysts

Str Sell (0)Sell (2)Hold (8)Buy (41)Str Buy (1)

Mean Target (qtr)$97.5714 targets

Target vs. Price+13.4%last-quarter mean

Next Report2026-10-29street $0.67

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$5.23B	$5.30B / $5.22B	$2.67	$2.73 / $2.48	16
FY2027	$5.80B	$5.91B / $5.71B	$3.13	$3.34 / $2.87	16
FY2028	$6.45B	$6.61B / $6.20B	$3.73	$4.07 / $2.95	7

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Month	$106.67	+24.0%	3
Last Quarter	$97.57	+13.4%	14
Last Year	$87.68	+1.9%	47
All Time	$84.75	-1.5%	90

Rolling mean of published targets vs. last close $86.04. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

B+

DCF

4/5

ROE

5/5

ROA

5/5

Debt/Eq

1/5

P/E

2/5

P/B

1/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

DXCM +29.7% vs S&P 500 +15.9% — spread +13.8pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$86.15	-0.11	-0.13%	Below
SMA 50	$87.55	-1.51	-1.72%	Below
SMA 200	$73.97	+12.07	+16.32%	Above
EMA 9	$85.58	+0.46	+0.54%	Above
EMA 21	$85.90	+0.14	+0.16%	Above
EMA 50	$85.00	+1.04	+1.22%	Above
EMA 200	$77.42	+8.62	+11.13%	Above

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

TECHNICAL VERDICTNEUTRALPower Score -114 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%44

Momentum 25%80

Volume 20%44

Volatility 10%17

Patterns 15%38

This Week45% bullishof 11 price-based votes

4 Weeks Ago73%-28 pts since

12 Weeks Ago36%+9 pts since

ReadStabilizingweek-over-week trajectory

Price vs SMA 20$86.15

Price vs SMA 50$87.55

Price vs SMA 200$73.97

EMA 9/21 Cross85.6/85.9

SMA 50/200Golden

ADX DirectionADX 11

Supertrend$90

Parabolic SAR$83

SMA Slope-0.170

RSI50.3

Stochastic K/D54/46

StochRSI K/D63/59

Williams %R-47

CCI39

TSI vs Signal-4.5

CMO0.5

ROC0.80%

OBV SignalDistrib

Chaikin MF0.010

MFI43

Force Index1M

Elder Ray Bull2.97

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 46

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$86.95 / $88.64 / $89.58	S1 / S2	$86.01 / $84.32
Bollinger (20,2)	$82.81 – $89.49	Squeeze	ON
52-wk range	$54.11 – $92.59	Off 52-wk high	-7.1%
ATR (14)	$2.47 (2.9%)	Historical vol	29.4%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

+6.1%Jan70%

+0.1%Feb40%

+0.8%Mar57%

+5.9%Apr60%

+1.3%May45%

+7.3%Jun80%

-1.2%Jul40%

+8.1%Aug60%

-3.7%Sep35%

-3.4%Oct35%

+3.0%Nov50%

+3.6%Dec50%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	DXCM	S&P 500
Weekly volatility (σ, 1y)	5.32%	1.83%
Best / worst week (1y)	+17.0% / -14.9%	—
Max drawdown (5y, monthly)	-63.6%	—
1-week VaR (95%)	-7.4%	—
Beta (5y)	1.42	1.00

DXCM EQUITY WEATHER (LIVE)RAINY · -21

Trend-22

Momentum+5

Volume-39

Volatility-30

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 211 stories, weekly buckets, −1 to +1.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Overall-20.7-0.5 vs industry

Trend-22.2-0.1 vs industry

Momentum+5.0+27.1 vs industry

Volume-38.8-33.8 vs industry

Reading	DXCM	Medical - Devices n=524	Healthcare n=5,272	All US symbols n=70,435
Overall	-20.7	-20.2	-24.0	-20.5
Trend	-22.2	-22.1	-25.6	-21.3
Momentum	+5.0	-22.0	-28.5	-15.8
Volume	-38.8	-5.0	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
Kevin Sayer Executive Chairman	$16.3M	92% equity+incentive
Jacob Leach President & Chief Executive Offi	$8.0M	89% equity+incentive
Jereme Sylvain EVP, Chief Financial Officer	$7.1M	90% equity+incentive
Jon Coleman EVP, Chief Commercial Officer	$6.7M	92% equity+incentive
Michael Brown EVP, Chief Legal Officer	$6.3M	90% equity+incentive

Pillar (live disclosure scores)	Score
Environmental	52
Social	51
Governance	61
Composite ESG	55

Composite ESG Trend

Filed	8-K contents	Items
2026-09-14	Officer/Director Change; Regulation FD; Exhibits	5.02,7.01,9.01
2026-09-10	Officer/Director Change; Regulation FD; Exhibits	5.02,7.01,9.01
2026-07-30	Earnings Release; Exhibits	2.02,9.01
2026-05-28	Shareholder Vote	5.07
2026-05-15	Regulation FD; Other Events	7.01,8.01
2026-04-30	Earnings Release; Exhibits	2.02,9.01
2026-03-02	Departure/Election of Directors; Appointment of Officers; Financial St	5.02,9.01
2026-02-26	Departure/Election of Directors; Appointment of Officers; Regulation F	5.02,7.01,9.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-10-27 to 2026-07-30
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	86 rows · 2005 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-08-20 to 2026-09-28
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	4 rows · 2025-04-24 to 2026-04-29
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

Institutions holding — 12 quarters

DexCom, Inc. (DXCM)

Monthly Net Insider Flow (000 shares)

Signal Summary

DexCom, Inc. (DXCM)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding DXCM — quarterly

Institutional Put/Call — quarterly

Where DXCM Trades in the Dark

DexCom, Inc. (DXCM)

3.8 · Employees (SEC filings)

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

Balance Sheet — Full

Cash Flow Statement — Full

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

Street Price Target — Trajectory

Third-Party Composite Rating

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

Family Scores (site weights)

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM)